Cite
ALDH+/CD44+ cells in breast cancer are associated with worse prognosis and poor clinical outcome.
MLA
Qiu, Yan, et al. “ALDH+/CD44+ Cells in Breast Cancer Are Associated with Worse Prognosis and Poor Clinical Outcome.” Experimental & Molecular Pathology, vol. 100, no. 1, Feb. 2016, pp. 145–50. EBSCOhost, https://doi.org/10.1016/j.yexmp.2015.11.032.
APA
Qiu, Y., Pu, T., Guo, P., Wei, B., Zhang, Z., Zhang, H., Zhong, X., Zheng, H., Chen, L., Bu, H., & Ye, F. (2016). ALDH+/CD44+ cells in breast cancer are associated with worse prognosis and poor clinical outcome. Experimental & Molecular Pathology, 100(1), 145–150. https://doi.org/10.1016/j.yexmp.2015.11.032
Chicago
Qiu, Yan, Tianjie Pu, Peng Guo, Bing Wei, Zhang Zhang, Hongying Zhang, Xiaorong Zhong, et al. 2016. “ALDH+/CD44+ Cells in Breast Cancer Are Associated with Worse Prognosis and Poor Clinical Outcome.” Experimental & Molecular Pathology 100 (1): 145–50. doi:10.1016/j.yexmp.2015.11.032.